Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19...
read more
Wednesday, January 11, 2017
endpoint, an interactive response technology (IRT®) solutions company, has been selected as the sole IRT provider for Ferring Pharmaceuticals AS, a biopharmaceutical company based in Denmark.
read more
endpoint Clinical announces the launch of their partnership program, ConnectionPOINT™, the first of its kind in the eClinical technology space.
read more
Endpoint Clinical announced an enhancement to its proprietary Pulse platform, remodeling how its interactive response technology is applied to clinical trials.
read more
Friday, February 12, 2021
endpoint Clinical has appointed Christine Hurley as its Senior Vice President, Client Services.
read more
Endpoint Clinical and Clinical Ink have teamed up to integrate IRT and eSource in order to create a seamless user experience for investigator sites.
read more
Endocyte and ITM Isotopen Technologien München announced ITM´s subsidiary Endocyte have signed a long-term global supply agreement for Lutetium-177 EndolucinBeta to support clinical and commercial supply of 177Lu-PSMA-617.
read more
Wednesday, August 15, 2018
Endo International announced that it is lifting a temporary stay of its litigation against the FDA.
read more
Wednesday, August 21, 2019
Endo International has applauded the U.S. District Court for the District of Columbia's decision supporting the Food and Drug Administration's (FDA) determination that vasopressin cannot be used for compounding by outsourcing facilities. The Court ...
read more
Wednesday, November 17, 2021
Endo International plc announced that its subsidiary, Par Sterile Products, LLC (Par Sterile), has entered into a cooperative agreement to expand its sterile fill-finish manufacturing production capacity and capabilities at its Rochester, Michigan ...
read more
Wednesday, April 17, 2019
Encube Ethicals has announced its new high potency manufacturing facility for topical formulations is now fully operational.
read more
Enable Injections has entered into a multi-product development agreement with Sanofi S.A.
read more
Emulate, Inc. has announced a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®) that seeks to integrate Emulate’s Organs-on-Chips technology into preclinical drug evaluation and testing services.
read more
EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD).
read more
Wednesday, February 20, 2019
Empire Genomics announced the appointments of Andy Watson as CEO and Anthony Scarpello to Chief Commercialization Officer, and the opening of its new headquarters in Williamsville, NY.
read more